Octapharma USA Inc drugs
7 results
Nuwiq (antihemophilic factor (recombinant))
(Antihemophilic Factor (Recombinant))Octapharma USA Inc
Usage: NUWIQ is a recombinant antihemophilic factor indicated for on-demand treatment and control of bleeding episodes, perioperative management, and routine prophylaxis in patients with Hemophilia A. It is not intended for treating von Willebrand disease.
Octagam immune globulin (human) (immune globulin)
(Immune Globulin)Octapharma USA Inc
Usage: Octagam is indicated for the treatment of primary humoral immunodeficiency diseases (PI), including congenital agammaglobulinemia, common variable immunodeficiency, X-linked agammaglobulinemia, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies. It is administered as a 5% intravenous immune globulin solution.
Octagam immune globulin (human) (immune globulin)
(Immune Globulin)Octapharma USA Inc
Usage: Octagam 10% is indicated for treating chronic immune thrombocytopenic purpura (ITP) to quickly raise platelet counts and prevent bleeding in adults, as well as for the treatment of dermatomyositis in adults.
Octaplas (human plasma proteins)
(human plasma proteins)Octapharma USA Inc
Usage: Octaplas is indicated for the replacement of multiple coagulation factors in patients with acquired deficiencies due to liver disease, as well as for use during cardiac surgery, liver transplantation, and plasma exchange in thrombotic thrombocytopenic purpura (TTP).
Octaplas (human plasma proteins)
(human plasma proteins)Octapharma USA Inc
Usage: Octaplas is indicated for the replacement of multiple coagulation factors in patients with acquired deficiencies due to liver disease, during cardiac surgery and liver transplantation, as well as for plasma exchange in patients with thrombotic thrombocytopenic purpura (TTP).
Octaplas (human plasma proteins)
(human plasma proteins)Octapharma USA Inc
Usage: Octaplas is indicated for the replacement of multiple coagulation factors in patients with acquired deficiencies due to liver disease, during cardiac surgery, and liver transplantation, as well as for plasma exchange in patients with thrombotic thrombocytopenic purpura (TTP).
Octaplas (human plasma proteins)
(human plasma proteins)Octapharma USA Inc
Usage: Octaplas is indicated for the replacement of multiple coagulation factors in patients with acquired deficiencies due to liver disease, and for use during cardiac surgery and liver transplantation. It is also used for plasma exchange in patients with thrombotic thrombocytopenic purpura (TTP).